Supply chain security continues to be a major customer issue across various industries. In the biopharma industry specifically, the public outcry for quality and transparency has caused a great deal of change in the global regulatory environment and in many company’s approach to the way they do business. SAFC is no exception.
As a company that likes to stay ahead of the trends, quality has long been a focus area for SAFC. From employing various global teams dedicated to quality and supply chain transparency, to re-categorizing product offerings to include fully validated products, SAFC has been busy working on answering this industry need.
Originally launched in 2012, SAFC’s PharmaGrade portfolio addresses the need for greater supply chain transparency and enhanced quality for biopharmaceutical manufacturing applications. Products in the PharmaGrade portfolio are provided with full documentation of manufacturing history, and are compliant with either GMP (Good Manufacturing Practice) standards or the SAFC Elite Quality grade standards. All PharmaGrade products are quality assurance reviewed and released, and include applicable change control notification, plus a dedicated product support team.
Here, SAFC’s own Beth Ann McLane, product manager for enhanced quality, talks supply chain security with Cynthia Challener of Pharmaceutical Sciences, Manufacturing, and Marketplace Report. The following feature titled Strategies for Achieving Biopharmaceutical Supply Chain, takes a look into how SAFC is ensuring supply-chain transparency and quality for raw materials with the PharmaGrade line.
The PharmaGrade line recently expanded to include 20 new products, and SAFC expects the portfolio to double in size by the end of 2013.The full press release on the expansion can be found by clicking here.
To learn more about PharmaGrade, please visit: www.safcglobal.com/pharmagrade